Abstract
Purpose of Review
The risks of developing cancer and dementia both increase with age, giving rise to the complex question of whether continued cancer screening for older dementia patients is appropriate. This paper offers a practice-based clinical approach to determine an answer to this challenging question.
Recent Findings
There is no consensus on the prevalence of cancer and dementia as co-diagnoses. Persons with dementia are screened less often compared to those without dementia. There is significant literature focusing on screening in the geriatric population, but there is little evidence to support decision-making for screening for older patients with dementia.
Summary
Given this lack of evidence, individualized decisions should be made in collaboration with patients and family caregivers. Four considerations to help guide this process include prognosis, behavioral constraints, cognitive capacity, and goals for care. Future research will be challenging due to variability of factors that inform screening decisions and the vulnerable nature of this patient population.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Gale SA, Acar D, Daffner KR. Dementia. Am J Med. 2018;131(10):1161–9.
Greenblat C. Dementia World Health Organization 2020 [updated September 21, 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia.
Raik BL, Miller FG, Fins JJ. Screening and cognitive impairment: ethics of forgoing mammography in older women. J Am Geriatr Soc. 2004;52(3):440–4.
•• 2020 Alzheimer's disease facts and figures. Alzheimers Dement. 2020. This article summarized the current public health impact of Alzheimer’s disease in the United States and provides basic information regarding it’s epidemiology, pathology, morbidity/mortality, and the role of the caregiver.
• McWilliams L, Farrell C, Grande G, Keady J, Swarbrick C, Yorke J. A systematic review of the prevalence of comorbid cancer and dementia and its implications for cancer-related care. Aging Ment Health. 2018;22(10):1254–71 This article provided a review of the literature to determine the prevalence rates of cancer-dementia. This article found the rates of cancer and dementia varied from 0.2% to 45.6%.
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):270–9.
Lee SJ, Boscardin WJ, Stijacic-Cenzer I, Conell-Price J, O'Brien S, Walter LC. Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. Bmj. 2013;346:e8441.
Morgans AK, Dale W, Briganti A. Screening and treating prostate cancer in the older patient: decision making across the clinical spectrum. Am Soc Clin Oncol Educ Book. 2017;37:370–81.
Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, et al. Early detection of prostate cancer: AUA Guideline. J Urol. 2013;190(2):419–26.
Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010;60(2):70–98.
Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on colorectal cancer. Am J Gastroenterol. 2017;112(7):1016–30.
Choosing Wisely: American Geriatrics Society 2015 [Available from: https://www.choosingwisely.org/clinician-lists/american-geriatrics-society-breast-colorectal-prostate-cancer-screening-in-older-adults/.
Walter LC, Eng C, Covinsky KE. Screening mammography for frail older women: what are the burdens? J Gen Intern Med. 2001;16(11):779–84.
•• Schoenborn NL, Boyd CM, Lee SJ, Cayea D, Pollack CE. Communicating about stopping cancer screening: comparing clinicians' and older adults' perspectives. Gerontologist. 2019;59(Suppl 1):S67–s76 This article provided insight in how clinicians and patients view stopping cancer screening. Three major themes were illustrated: 1) Importance of discussing the risks/benefits and involving patients in decision making, 2) Clinicians were more concerned with patient reactions to stopping screening compared to older adults, who reported no negative reactions in the context of a trusing relationship. 3) While clinicians rarely addressed life expectancy in discussions, older adults were mixed in wanting this information as part of the discussion.
Eckstrom E, Feeny DH, Walter LC, Perdue LA, Whitlock EP. Individualizing cancer screening in older adults: a narrative review and framework for future research. J Gen Intern Med. 2013;28(2):292–8.
Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314(15):1599–614.
Siu AL. Screening for Breast Cancer: U.S. Preventive services task force recommendation statement. Ann Intern Med. 2016;164(4):279–96.
Practice Bulletin Number 179: breast cancer risk assessment and screening in average-risk women. Obstet Gynecol. 2017;130(1):e1–e16.
Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, et al. Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019;69(3):184–210.
Force UPST. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2016;315(23):2564–75.
Wender R, Fontham ETH, Barrera E Jr, Colditz GA, Church TR, Ettinger DS, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63(2):106–17.
Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med. 2013;159(6):411–20.
Mazzone PJ, Silvestri GA, Patel S, Kanne JP, Kinsinger LS, Wiener RS, et al. Screening for lung cancer: CHEST guideline and expert panel report. Chest. 2018;153(4):954–85.
Moyer VA. Screening for prostate cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2012;157(2):120–34.
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis. 2012;16(3):175–204.
Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Screening for cervical cancer: US preventive services task force recommendation statement. JAMA. 2018;320(7):674–86.
Seely JM, Alhassan T. Screening for breast cancer in 2018-what should we be doing today? Curr Oncol. 2018;25(Suppl 1):S115–s24.
• Law M, Dhillon S, Herrmann N, Friesen F, Dey AK, Li A, et al. Rates of screening for breast, colorectal, and cervical cancers in older people with cognitive impairment or dementia: a meta-analysis. Gerontol Geriatr Med. 2018;4:2333721418799446 This meta-analysis found breast cancer screening occurred less frequently in those with cognitive impairement or dementia. However, there were not statistically lower in colorectal or cervical screening rates for those patients with cognitive impairement or dementia.
Walter LC, Lindquist K, Nugent S, Schult T, Lee SJ, Casadei MA, et al. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med. 2009;150(7):465–73.
Mehta KM, Fung KZ, Kistler CE, Chang A, Walter LC. Impact of cognitive impairment on screening mammography use in older US women. Am J Public Health. 2010;100(10):1917–23.
Xie J, Brayne C, Matthews FE. Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. Bmj. 2008;336(7638):258–62.
Hodges JR, Davies R, Xuereb J, Kril J, Halliday G. Survival in frontotemporal dementia. Neurology. 2003;61(3):349–54.
Garre-Olmo J, Ponjoan A, Inoriza JM, Blanch J, Sánchez-Pérez I, Cubí R, et al. Survival, effect measures, and impact numbers after dementia diagnosis: a matched cohort study. Clin Epidemiol. 2019;11:525–42.
Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004;140(7):501–9.
Graff-Radford J. Rapidly progressing Alzheimer’s: Something else? Mayo Clinic 2019 [updated April 23, 2019. Available from: https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/expert-answers/alzheimers/faq-20058510.
Ferrari C, Lombardi G, Polito C, Lucidi G, Bagnoli S, Piaceri I, et al. Alzheimer's disease progression: factors influencing cognitive decline. J Alzheimers Dis. 2018;61(2):785–91.
Schoenborn NL, Massare J, Park R, Boyd CM, Choi Y, Pollack CE. Assessment of clinician decision-making on cancer screening cessation in older adults with limited life expectancy. JAMA Netw Open. 2020;3(6):e206772.
Brauner DJ, Muir JC, Sachs GA. Treating nondementia illnesses in patients with dementia. JAMA. 2000;283(24):3230–5.
ePrognosis. ePrognosis n.d. [Available from: https://eprognosis.ucsf.edu.
Halpern R, Seare J, Tong J, Hartry A, Olaoye A, Aigbogun MS. Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia. Int J Geriatr Psychiatry. 2019;34(3):420–31.
Torke AM, Schwartz PH, Holtz LR, Montz K, Sachs GA. Caregiver perspectives on cancer screening for persons with dementia: "why put them through it?". J Am Geriatr Soc. 2013;61(8):1309–14.
•• Martin C, Shrestha A, Burton M, Collins K, Wyld L. How are caregivers involved in treatment decision making for older people with dementia and a new diagnosis of cancer? Psychooncology. 2019;28(6):1197–206 This systematic review found that clinicians were often not aware of the co-existence of dementia in those patients with a new cancer diagnosis, which leads to unmet care needs including that primary caregivers feel excluded from decision making.
Balducci L, Dolan D. Palliative Care of Cancer in the Older Patient. Curr Oncol Rep. 2016;18(12):70.
Daly RL, Bunn F, Goodman C. Shared decision-making for people living with dementia in extended care settings: a systematic review. BMJ Open. 2018;8(6):e018977.
Saur NM, Montroni I. Geriatric Comanagement: A Secret Ingredient of the Elusive Recipe. JAMA Netw Open. 2020;3(8):e209460.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors
Conflict of Interest
None of the authors has any potential conflicts of interest to disclose
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Palliative Medicine
Rights and permissions
About this article
Cite this article
Kuwata, C., Goldhirsch, S.L. & Rodríguez, V. Navigating the Cancer Screening Decision for Patients with Dementia. Curr Oncol Rep 23, 90 (2021). https://doi.org/10.1007/s11912-021-01083-1
Accepted:
Published:
DOI: https://doi.org/10.1007/s11912-021-01083-1